Trademarkia Logo

Australia

AU$
OMCRYXA
Cancelled: Cancelled at the request of IB

Last updated on 9 May 2021

Owner Info

Recro Pharma, Inc.

490 Lapp Road

Malvern PA 19355, UNITED STATES OF AMERICA

Serial Number

1838104 filed on 20 Jan 2017

Correspondent

Pepper Hamilton LLP

The New York Times Building,,

37th Floor,,

UNITED STATES OF AMERICA

OMCRYXA

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of pain

Mark Details


Serial Number

1838104

Registered On

20 Jan 2017

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

2 Nov 2016

Mark Type

US

Legal History


Show more

Status DateAction Taken
9th May 2021Status change to Voided
18th Jun 2020Amendment to International Registration Contact Requested
17th Apr 2020Customer Amendment Made correspondence sent
9th Apr 2020Amendment to Address for Service Requested
20th Jul 2017IP Right Registration Published
12th Jul 2017Register Trade Mark
12th Jul 2017Application Status
1st Jun 2017Amendment to Application/Registration
4th May 2017IP Right Acceptance Published
27th Apr 2017Clear Examination report approved